142 related articles for article (PubMed ID: 15205195)
1. 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers.
Noordhuis P; Holwerda U; Van der Wilt CL; Van Groeningen CJ; Smid K; Meijer S; Pinedo HM; Peters GJ
Ann Oncol; 2004 Jul; 15(7):1025-32. PubMed ID: 15205195
[TBL] [Abstract][Full Text] [Related]
2. The Critical Function of microRNAs in Developing Resistance against 5- Fluorouracil in Cancer Cells.
Sheikhnia F; Maghsoudi H; Majidinia M
Mini Rev Med Chem; 2024; 24(6):601-617. PubMed ID: 37642002
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of methionine-depleting total parenteral nutrition with 5-fluorouracil on human gastric cancer: a randomized, prospective clinical trial.
Goseki N; Yamazaki S; Shimojyu K; Kando F; Maruyama M; Endo M; Koike M; Takahashi H
Jpn J Cancer Res; 1995 May; 86(5):484-9. PubMed ID: 7790321
[TBL] [Abstract][Full Text] [Related]
4. Standing the test of time: targeting thymidylate biosynthesis in cancer therapy.
Wilson PM; Danenberg PV; Johnston PG; Lenz HJ; Ladner RD
Nat Rev Clin Oncol; 2014 May; 11(5):282-98. PubMed ID: 24732946
[TBL] [Abstract][Full Text] [Related]
5. Prevention by chitosan of myelotoxicity, gastrointestinal toxicity and immunocompetent organic toxicity induced by 5-fluorouracil without loss of antitumor activity in mice.
Kimura Y; Okuda H
Jpn J Cancer Res; 1999 Jul; 90(7):765-74. PubMed ID: 10470290
[TBL] [Abstract][Full Text] [Related]
6. A forward genetic approach for analyzing the mechanism of resistance to the anti-cancer drug, 5-fluorouracil, using Caenorhabditis elegans.
Kim S; Shim J
Mol Cells; 2008 Feb; 25(1):119-23. PubMed ID: 18319623
[TBL] [Abstract][Full Text] [Related]
7. Participation of DNA repair in the response to 5-fluorouracil.
Wyatt MD; Wilson DM
Cell Mol Life Sci; 2009 Mar; 66(5):788-99. PubMed ID: 18979208
[TBL] [Abstract][Full Text] [Related]
8. An RNA Damage Response Network Mediates the Lethality of 5-FU in Clinically Relevant Tumor Types.
Chen JK; Merrick KA; Kong YW; Izrael-Tomasevic A; Eng G; Handly ED; Patterson JC; Cannell IG; Suarez-Lopez L; Hosios AM; Dinh A; Kirkpatrick DS; Yu K; Rose CM; Hernandez JM; Hwangbo H; Palmer AC; Vander Heiden MG; Yilmaz ÖH; Yaffe MB
bioRxiv; 2023 Apr; ():. PubMed ID: 37162991
[TBL] [Abstract][Full Text] [Related]
9. 5-Fluorouracil Treatment Represses Pseudouridine-Containing Small RNA Export into Extracellular Vesicles.
Qu S; Nelson H; Liu X; Semler E; Michell DL; Massick C; Franklin JL; Karijolich J; Weaver AM; Coffey RJ; Liu Q; Vickers KC; Patton JG
bioRxiv; 2024 Jan; ():. PubMed ID: 38293013
[TBL] [Abstract][Full Text] [Related]
10. The incorporation of 5-fluorouracil into RNA affects the ribonucleolytic activity of the exosome subunit Rrp6.
Silverstein RA; González de Valdivia E; Visa N
Mol Cancer Res; 2011 Mar; 9(3):332-40. PubMed ID: 21289297
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluorouracil incorporated into DNA is excised by the Smug1 DNA glycosylase to reduce drug cytotoxicity.
An Q; Robins P; Lindahl T; Barnes DE
Cancer Res; 2007 Feb; 67(3):940-5. PubMed ID: 17283124
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of action of FdUMP[10]: metabolite activation and thymidylate synthase inhibition.
Bijnsdorp IV; Comijn EM; Padron JM; Gmeiner WH; Peters GJ
Oncol Rep; 2007 Jul; 18(1):287-91. PubMed ID: 17549381
[TBL] [Abstract][Full Text] [Related]
13. 5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes.
Blondy S; David V; Verdier M; Mathonnet M; Perraud A; Christou N
Cancer Sci; 2020 Sep; 111(9):3142-3154. PubMed ID: 32536012
[TBL] [Abstract][Full Text] [Related]
14. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future.
Vodenkova S; Buchler T; Cervena K; Veskrnova V; Vodicka P; Vymetalkova V
Pharmacol Ther; 2020 Feb; 206():107447. PubMed ID: 31756363
[TBL] [Abstract][Full Text] [Related]
15. Novel insights into the role of translesion synthesis polymerase in DNA incorporation and bypass of 5-fluorouracil in colorectal cancer.
Averill JR; Lin JC; Jung J; Jung H
Nucleic Acids Res; 2024 May; 52(8):4295-4312. PubMed ID: 38416579
[TBL] [Abstract][Full Text] [Related]
16. MiR-548c-3p through suppressing
Khalili E; Afgar A; Rajabpour A; Aghaee-Bakhtiari SH; Jamialahmadi K; Teimoori-Toolabi L
Heliyon; 2023 Nov; 9(11):e21775. PubMed ID: 38045156
[TBL] [Abstract][Full Text] [Related]
17. Unnatural Amino Acid Engineering for Intracellular Delivery of Protein Therapeutics.
Chen W; Sullivan MO
Methods Mol Biol; 2024; 2720():151-164. PubMed ID: 37775664
[TBL] [Abstract][Full Text] [Related]
18. Enhancing the Effective Chemotherapy: The Combined Inhibition of Rhinacanthin-C, 5-Fluorouracil, and Etoposide on Oral Cancer Cells.
Klaophimai S; Pouyfung P; Chairatvit K
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2405-2412. PubMed ID: 37505773
[TBL] [Abstract][Full Text] [Related]
19. Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects.
Gmeiner WH; Okechukwu CC
Cancer Drug Resist; 2023; 6(2):257-272. PubMed ID: 37457133
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
